NK/T-CELL LYMPHOMA

Clinical trials for NK/T-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new NK/T-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for NK/T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 3 Not yet finished but already full! 1 Completed 1 Terminated 1

New hope for lymphoma patients after chemo fails

Disease control Completed

This study tested whether the drug brentuximab vedotin could help control T-cell lymphoma that had returned or stopped responding to previous chemotherapy. The trial enrolled 23 patients whose cancer cells had low levels of a specific target called CD30. Researchers wanted to see…

Matched conditions: NK/T-CELL LYMPHOMA

Phase: PHASE2 • Sponsor: Deepa Jagadeesh • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

NK/T-CELL LYMPHOMA

Get alerted when new NK/T-CELL LYMPHOMA trials appear

New hope for lymphoma patients after chemo fails